Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia

Sohn, Sang Kyun; Oh, Suk Joong; Kim, Byung Soo; Ryoo, Hun Mo; Chung, Joo Seop; Joo, Young Don; Bang, Soo Mee; Jung, Chul Won; Kim, Dong Hwan; Yoon, Sung Soo; Kim, Ho; Lee, Hong Ghi; Won, Jong Ho; Min, Yoo Hong; Cheong, June Won; Park, Joon Seong; Eom, Ki Seong; Hyun, Myung Soo; Kim, Min Kyoung; Kim, Hawk; Park, Moo Rim; Park, Jinny; Kim, Chul Soo; Kim, Hyeoung Joon; Kim, Yeo Kyeoung; Park, Eun Kyung; Zang, Dae Young; Jo, Deog Yeon; Moon, Joon Ho; Park, Seon Yang

期刊名称Leukemia & Lymphoma
作者Sohn, Sang Kyun; Oh, Suk Joong; Kim, Byung Soo; Ryoo, Hun Mo; Chung, Joo Seop; Joo, Young Don; Bang, Soo Mee; Jung, Chul Won; Kim, Dong Hwan; Yoon, Sung Soo; Kim, Ho; Lee, Hong Ghi; Won, Jong Ho; Min, Yoo Hong; Cheong, June Won; Park, Joon Seong; Eom, Ki Seong; Hyun, Myung Soo; Kim, Min Kyoung; Kim, Hawk; Park, Moo Rim; Park, Jinny; Kim, Chul Soo; Kim, Hyeoung Joon; Kim, Yeo Kyeoung; Park, Eun Kyung; Zang, Dae Young; Jo, Deog Yeon; Moon, Joon Ho; Park, Seon Yang
卷第52卷
期第6期
印刷ISSN1042-8194
电子ISSN1029-2403
文件大小250.12KB
发表时间2011-06
DOI10.3109/10428194.2011.563885
页码1024-1029

发现好书期刊，享受阅读乐趣

Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia